Elite in Polymyalgia Rheumatica

Frank Buttgereit

Berlin, BE, DE 
Elite in Polymyalgia Rheumatica
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Frank Buttgereit practices in Berlin, Germany. Mr. Buttgereit is rated as an Elite expert by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Rheumatoid Arthritis (RA), Arthritis, and Osteotomy.

His clinical research consists of co-authoring 280 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 26 articles in the study of Polymyalgia Rheumatica.

Gender
Male

Locations

Berlin, BE, Germany
Other Locations
Tuebingen, BW, Germany
Mitte, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Multi-Center, Double-Blind, Placebo-Controlled Study of a New Modified-Release Tablet Formulation of Prednisone (Lodotra®) in Patients With Rheumatoid Arthritis
A Randomized Multi-Center, Double-Blind, Placebo-Controlled Study of a New Modified-Release Tablet Formulation of Prednisone (Lodotra®) in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Phase: Phase 3
A New Timed-Release Tablet Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis- A Randomized, Multi-Centre, Double-Blind, Active Controlled Study With Open Extension on the New Drug Only
A New Timed-Release Tablet Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis- A Randomized, Multi-Centre, Double-Blind, Active Controlled Study With Open Extension on the New Drug Only
Enrollment Status: Completed
Publish Date: July 03, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

280 Total Publications

Comment on: Glucocorticoid discontinuation in systemic lupus erythematosus: a single-centre study.
Comment on: Glucocorticoid discontinuation in systemic lupus erythematosus: a single-centre study.
Journal: Rheumatology advances in practice
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Buttgereit's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile